Giuseppe Ciaramella

Companies

• Beam TherapeuticsPresident Feb 5, 2020 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Beam Therapeutics BEAM253,911 shares²$6.1M at $24.00Sep 25, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 24, 2026Gift 123,407 shares of Beam Therapeutics²
• Jun 17, 2026Exercised options 29,000 shares at $1.03 of Beam Therapeutics³
• Jun 17, 2026Exercised options 6,505 shares at $0.67 of Beam Therapeutics³
• Apr 1, 2026Sold 11,810 shares at $24.58 of Beam Therapeutics⁴
• Mar 31, 2026Granted 40,000 shares of Beam Therapeutics⁵
• Feb 24, 2026Sold 35,000 shares at $32.00 of Beam Therapeutics⁶
• Feb 24, 2026Exercised options 35,000 shares at $17.00 of Beam Therapeutics⁶
• Apr 1, 2025Sold 7,434 shares at $18.35 of Beam Therapeutics⁷
• Mar 31, 2025Granted 35,000 shares of Beam Therapeutics⁸
• Dec 17, 2024Exercised options 53,500 shares at $0.67 of Beam Therapeutics⁹
• Nov 6, 2024Sold 51,110 shares at $26.36 of Beam Therapeutics¹⁰
• Oct 14, 2024Sold 51,110 shares at $26.27 of Beam Therapeutics¹¹
• Oct 14, 2024Exercised options 1,457 shares at $7.22 of Beam Therapeutics¹¹
• Oct 14, 2024Exercised options 12,979 shares at $4.22 of Beam Therapeutics¹¹
• Oct 14, 2024Exercised options 27,318 shares at $0.67 of Beam Therapeutics¹¹
• Apr 1, 2024Sold 4,534 shares at $32.12 of Beam Therapeutics¹²
• Mar 31, 2024Granted 35,000 shares of Beam Therapeutics¹³
• Oct 20, 2023Exercised options 90,900 shares at $0.67 of Beam Therapeutics¹⁴
• Jul 24, 2023Sold 1,206 shares at $32.01 of Beam Therapeutics¹⁵
• Jul 24, 2023Exercised options 1,206 shares at $7.22 of Beam Therapeutics¹⁵
• Jul 21, 2023Sold 155,324 shares at $32.06 of Beam Therapeutics¹⁵
• Jul 21, 2023Exercised options 21,846 shares at $7.22 of Beam Therapeutics¹⁵
• Jul 21, 2023Exercised options 69,438 shares at $7.22 of Beam Therapeutics¹⁵
• Apr 4, 2023Sold 1,754 shares at $29.09 of Beam Therapeutics¹⁶
• Apr 3, 2023Sold 1,918 shares at $30.31 of Beam Therapeutics¹⁶